ReviewInsulin resistance and the endothelium
Section snippets
Endothelial dysfunction predicts cardiovascular disease
Endothelial function in a peripheral or coronary artery can be viewed as a vasodilatory response to acetylcholine or methacholine, which directly stimulate nitric oxide production, or to hyperemia, which can be achieved in a peripheral artery by blood pressure cuff inflation or cold pressor testing. Abnormal vasomotive responses occur in the presence of traditional risk factors, such as hypercholesterolemia, hypertension, smoking, diabetes, low high-density lipoprotein (HDL) cholesterol levels,
The endothelium in the spectrum of insulin resistance
Increasing evidence suggests that the progression of insulin resistance to type 2 diabetes parallels the progression of endothelial dysfunction to atherosclerosis (Figure). Insulin resistance is closely linked with visceral adiposity, and early data suggested that free fatty acids were responsible for this association, since free fatty acids are increased in adiposity as a result of increased lipolysis. Free fatty acids were found to inhibit insulin-mediated glucose uptake by decreasing
Improving endothelial function is associated with prevention of diabetes
A number of approaches that improve endothelial function prevent both diabetes and cardiovascular disease, underscoring the close relation between the endothelium and insulin action (Table 4). Statins, ACE inhibitors, and angiotensin receptor blockers improve endothelial function and, in major clinical trials, reduce both cardiovascular disease and new-onset type 2 diabetes 47, 48, 49. Exercise and weight loss also improve endothelial function. The recently completed Diabetes Prevention
The effect of thiazolidinediones on endothelial function
Thiazolidinediones are a class of therapeutic agents that activate peroxisome proliferator-activated receptor γ (PPAR-γ), a nuclear receptor that enhances insulin-mediated glucose uptake into insulin target tissues, such as the skeletal muscle, heart, and adipose (58). To date, only three drugs in this class have been approved for medical use: pioglitazone, rosiglitazone, and troglitazone, although troglitazone has since been withdrawn from the market. Thiazolidinediones have direct effects on
The effect of statins on endothelial function
Statins are the current drugs of choice for the treatment of hypercholesterolemia. They block the conversion of 3-hydroxy-3-methylglutaryl coenzyme A to mevalonate, thereby inhibiting an early rate-limiting step in cholesterol biosynthesis. Statins reduce serum LDL and increase HDL cholesterol levels, and liver LDL receptor expression, with an associated increase in cholesterol clearance.
Statins have beneficial effects on the vascular bed, increasing vascular eNOS activity and synthesis, while
Inhibition of the renin-angiotensin system and other approaches
Angiotensin II has several pro-oxidative effects on the vasculature, decreasing nitric oxide bioavailability and resulting in vascular injury. ACE inhibitors are known to improve endothelial dysfunction, but the ability of angiotensin receptor blockers to improve endothelial dysfunction is less clear 45, 94. Both drug classes consistently prevent coronary artery (particularly in the case of ACE inhibitors), stroke, and diabetic microvascular complications of nephropathy and retinopathy (95).
Conclusion
There is increasing evidence to suggest a parallel progression between insulin resistance and endothelial dysfunction. The PPAR-γ ligands clearly improve insulin sensitivity and endothelial function. They may slow the progression of carotid intima-media thickness, which mirrors atherosclerotic changes in the coronary arteries (98). Growing evidence on PPAR-γ ligands, including their effects on reversing the metabolic syndrome, inhibiting vascular inflammation, and improving endothelial
References (98)
Endothelial dysfunctionDoes it matter? is it reversible?
J Am Coll Cardiol
(1997)Angiotensin II and the pathophysiology of cardiovascular remodeling
Am J Cardiol
(2001)- et al.
Endothelin-1 and atherosclerosisPotential complications associated with endothelin-receptor blockade
Atherosclerosis
(2002) - et al.
Oral administration of the nitric oxide biosynthesis inhibitor, L-nitro-arginine methyl ester (L-NAME), causes hypertension, but not glucose intolerance or insulin resistance, in rats
Am J Hypertension
(1995) The adipocyte in insulin resistanceKey molecules and the impact of the thiazolidinediones
Trends Endocrinol Metab
(2003)- et al.
Constantly low HDL-cholesterol concentration relates to endothelial dysfunction and increased in vivo LDL-oxidation in healthy young men
Atherosclerosis
(1999) Endothelial dysfunction associated with oxidative stress in human
Diabetes Res Clin Practice
(2001)Inflammatory pathways in atherosclerosis and acute coronary syndromes
Am J Cardiol
(2001)- et al.
Adiponectin, a new member of the family of soluble defense collagens, negatively regulates the growth of myelomonocytic progenitors and the functions of macrophages
Blood
(2000) - et al.
Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE)A randomised trial against atenolol
Lancet
(2002)
Cardiovascular morbidity and mortality in patients with diabetes in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE)A randomised trial against atenolol
Lancet
The effects of troglitazone, an insulin-sensitizing agent, on the endothelial function in early and late type 2 diabetesA placebo-controlled randomized clinical trial
Metabolism
Insulin action enhancement normalizes brachial artery vasoactivity in patients with peripheral vascular disease and occult diabetes
J Vasc Surg
Effects of rosiglitazone alone and in combination with atorvastatin on the metabolic abnormalities in type 2 diabetes mellitus
Am J Cardiol
Vascular protective effects by activation of nuclear receptor PPARγ
J Diabetes Complications
Post-transcriptional regulation of endothelial nitric oxide synthase mRNA stability by Rho GTPase
J Biol Chem
Lipophilic HMG-CoA reductase inhibitor has an anti-inflammatory effectReduction of MRNA levels for interleukin-1beta, interleukin-6, cyclooxygenase-2, and p22phox by regulation of peroxisome proliferator-activated receptor alpha (PPARalpha) in primary endothelial cells
Life Sci
Reduction of platelet activity markers in type II hypercholesterolemic patients by a HMG-CoA-reductase inhibitor
Thromb Res
Familial Hypercholesterolaemia Regression StudyA randomised trial of low-density-lipoprotein apheresis
Lancet
Angiotensin II induces migration and Pyk2/paxillin phosphorylation of human monocytes
Hypertension
Angiotensin II induces vascular cell adhesion molecule-1 expression in rat vasculatureA potential link between the renin-angiotensin system and atherosclerosis
Circulation
Angiotensin II induces monocyte chemoattractant protein-1 gene expression in rat vascular smooth muscle cells
Circ Res
Angiotensin II regulates the expression of plasminogen activator inhibitor-1 in cultured endothelial cells. A potential link between the renin-angiotensin system and thrombosis
J Clin Invest
Tissue angiotensin and pathobiology of vascular diseaseA unifying hypothesis
Hypertension
Lessons from genetically engineered animal models. IV. Nitric oxide synthase gene knockout mice
Am J Physiol Gastrointest Liver Physiol
Acceleration of atherosclerotic lesions in transgenic mice with hypertension by the activated renin-angiotensin system
Lab Invest
Angiotensin II promotes atherosclerotic lesions and aneurysms in apolipoprotein E-deficient mice
J Clin Invest
Chronic angiotensin II infusion promotes atherogenesis in low density lipoprotein receptor -/- mice
Ann N Y Acad Sci
The angiotensin-converting enzyme inhibitor, fosinopril, and the angiotensin II receptor antagonist, losartan, inhibit LDL oxidation and attenuate atherosclerosis independent of lowering blood pressure in apolipoprotein E deficient mice
Cardiovasc Res
Role of endothelial dysfunction in insulin resistance
Am J Cardiol
Prognostic implications of endothelial dysfunctionDoes it mean anything?
Coron Artery Dis
Long-term follow-up of patients with mild coronary artery disease and endothelial dysfunction
Circulation
Endothelial dysfunction is associated with subclinical atherosclerosis in insulin resistant patients
J Nucl Med
Endothelial dysfunction in acute coronary syndromesAssociation with elevated C-reactive protein levels
Ann Med
Endothelium-dependent vasodilatation, plasma markers of endothelial function, and adrenergic vasoconstrictor responses in type 1 diabetes under near-normoglycemic conditions
Diabetes
Novel modulator for endothelial adhesion moleculesAdipocyte-derived plasma protein adiponectin
Circulation
Peripheral endothelial dysfunction in heart transplant recipientsPossible role of proinflammatory cytokines
Clin Transplant
The central role of fat and effect of peroxisome proliferator-activated receptor-gamma on progression of insulin resistance and cardiovascular disease
Am J Cardiol
Free fatty acids in obesity and type 2 diabetesDefining their role in the development of insulin resistance and beta-cell dysfunction
Eur J Clin Invest
MinireviewAdiposity, inflammation, and atherogenesis
Endocrinology
Insulin resistance in healthy Mexican-Americans is associated with coronary artery endothelial dysfunction
Diabetes
Effects of long-term smoking on myocardial blood flow, coronary vasomotion, and vasodilator capacity
Circulation
Endothelial dysfunction is detectable in young normotensive first-degree relatives of subjects with type 2 diabetes in association with insulin resistance
Circulation
Role of oxidized LDL in atherosclerosis
Ann NY Acad Sci
Endothelial function in hypertensionThe role of superoxide anion
Hypertension
Elevated circulating free fatty acid levels impair endothelium-dependent vasodilation
J Clin Invest
Leptin in the regulation of immunity, inflammation, and hematopoiesis
J Leukoc Biol
Adipocyte-derived plasma protein, adiponectin, suppresses lipid accumulation and class A scavenger receptor expression in human monocyte-derived macrophages
Circulation
Cited by (211)
Association between cardiovascular disease risk and incident type 2 diabetes mellitus in individuals with prediabetes: A retrospective cohort study
2024, Diabetes Research and Clinical PracticeStudy on dengue severity in diabetic and non-diabetic population of tertiary care hospital by assessing inflammatory indicators
2022, Annals of Medicine and SurgeryRisk factors for hospitalization and mortality due to dengue fever in a Mexican population: a retrospective cohort study
2021, International Journal of Infectious DiseasesDistinct uric acid trajectories are associated with incident diabetes in an overweight Chinese population
2021, Diabetes and Metabolism